2020-10-20

1: Eaton GJ, Zhang QS, Diallo C, Matsuzawa A, Ichijo H, Steinbeck MJ, Freeman TA. 
Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone 
formation by increasing chondrocyte survival. Cell Death Dis. 2014 Nov 
13;5:e1522. doi: 10.1038/cddis.2014.480. PubMed PMID: 25393478; PubMed Central 
PMCID: PMC4260738.

2: Yoshida T, Ozawa Y, Suzuki K, Yuki K, Ohyama M, Akamatsu W, Matsuzaki Y, 
Shimmura S, Mitani K, Tsubota K, Okano H. The use of induced pluripotent stem 
cells to reveal pathogenic gene mutations and explore treatments for retinitis 
pigmentosa. Mol Brain. 2014 Jun 16;7:45. doi: 10.1186/1756-6606-7-45. PubMed 
PMID: 24935155; PubMed Central PMCID: PMC4058693.

3: El Eter E. NQDI 1, an inhibitor of ASK1 attenuates acute ischemic renal injury 
by modulating oxidative stress and cell death. Cardiovasc Hematol Agents Med 
Chem. 2013 Sep;11(3):179-86. PubMed PMID: 23952292.

4: Nomura K, Lee M, Banks C, Lee G, Morris BJ. An ASK1-p38 signalling pathway 
mediates hydrogen peroxide-induced toxicity in NG108-15 neuronal cells. Neurosci 
Lett. 2013 Aug 9;549:163-7. doi: 10.1016/j.neulet.2013.05.045. Epub 2013 Jun 4. 
PubMed PMID: 23742763.

5: Volynets GP, Chekanov MO, Synyugin AR, Golub AG, Kukharenko OP, Bdzhola VG, 
Yarmoluk SM. Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as 
inhibitors of apoptosis signal-regulating kinase 1 (ASK1). J Med Chem. 2011 Apr 
28;54(8):2680-6. doi: 10.1021/jm200117h. Epub 2011 Mar 30. PubMed PMID: 21449566.